Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Sorry, this entry is only available in 中文.類型: 連結 作者: Feng-Cai Zhu et al. 出處: The Lancet 連結:...